Desmopressin Acetate (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Desmopressin Acetate drug offered from Teva Pharmaceuticals USA, Inc.. This Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Desmopressin Acetate |
| SUBSTANCE NAME: | DESMOPRESSIN ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2006-01-27 |
| END MARKETING DATE: | 2017-12-31 |
Desmopressin Acetate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Desmopressin Acetate from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.1(mg/1) |
| START MARKETING DATE: | 2006-01-27 |
| END MARKETING DATE: | 2017-12-31 |
| PRODUCT ID: | 0093-7316_6c374f66-9e06-43bf-9dbc-392351f88d85 |
| PRODUCT NDC: | 0093-7316 |
| APPLICATION NUMBER: | ANDA077122 |
Other DESMOPRESSIN ACETATE Pharmaceutical Manufacturers / Labelers:
